Q32 Bio Inc. (0T6G.L) LSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 39.12M |
| Enterprise Value | 6.16M |
| P/E Ratio | 3.98 |
| PEG Ratio | 0.01 |
| Price/Sales Ratio | 6.15 |
| Price/Book Ratio | 1.48 |
| Enterprise/Revenue | 4.27 |
| Enterprise/EBITDA | 6.63 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | 0.63 |
| Operating Margin | 0.4 |
AD
Management Effectiveness
| Return On Assets | 0.29 |
| Return On Equity | 0.77 |
Income Statement
| Revenue | 53.74M |
| Revenue/Share | 3.81 |
| Gross Profit | 53.35M |
| EBITDA | 17.29M |
| Net Income | 29.82M |
| Diluted EPS | 2.42 |
Balance Sheet
| Total Cash | 106.27M |
| Total Cash/Share | 7.54 |
| Total Debt | 5.3M |
| Total Debt/Equity | 0.05 |
| Current Ratio | 20.3 |
| Book Value Per Share | 7.51 |
Price History
| 52-Week Change | 487.7 |
| 52-Week High | 10.99 |
| 52-Week Low | 0.46 |
| Moving Average 50 Days | 0.66 |
| Moving Average 200 Days | 0.88 |
Statistics
| Average Volume | 2,633 |
| Shares Outstanding | 12.78M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:18 |
| Last Split Date | March 27, 2024 |
AD
